Immatics N.V (NASDAQ:IMTX) does about 729.59K shares in volume on a normal day but saw 1356257 shares change hands in the recent trading day. The company now has a market cap of 746.32M USD. Its current market price is $6.14, marking an increase of 0.66% compared to the previous close of $6.10. The 52 week high reached by this stock is $13.23 whilst the lowest price level in 52 weeks is $3.30. The script in recent trading has seen the stock touch a high of $28 and a low of $16.
The consensus objective for the share price is $14.98, suggesting that the stock has a potential upside of 59.01% over the period. The median price target is 72.09% away from the current levels at $22.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 28, 2025 when Deutsche Bank initiated the stock to “Buy” and issued a price target of $10.
The current price level is 8.17%, 23.88%, and -11.42% away from its SMA20, SMA50, and SMA200 respectively, with the IMTX price moving below the 50-day SMA on current market day. Immatics N.V (IMTX) stock is up 3.37% over the week and 29.54% over the past month. Its price is -13.64% year-to-date and -52.59% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.36 and -1.43 for whole year. Expected sales for next quarter are $13.05M, which analysts say will come at $68.51M for the current fiscal year and next year at $58.68M. In addition, estimates put the company’s current quarterly revenue at an average of $13.05M.
Its 12-month price target is $22. To reach the target analysts have set, the stock logically needs to grow 59.01 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $16, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $28.
The company has a return on investment of -3.84% and return on equity of -4.52%. The beta has a value of 0.83. Price to book ratio is 1.29 and price to sales ratio is 4.81.
